Home Authors Posts by Giuliana Miglierini

Giuliana Miglierini

189 POSTS 0 COMMENTS

Biosimilars: the strategic imperative to balance between the needs for innovation...

EMA’s vision on evidence by design to evaluate the added therapeutic...

How to address the choice of an API supplier

Greece: The National Chamber of Pharmacists

Switzerland: The new Swiss regulatory framework

Transparency, still a long road to reach the goal

The EURIPID Collaboration for pricing and reimbursement

Transforming Big Pharma’s model

EMA’s first guideline on medical devices integral to medicinal products

Belgium: Impact of the emergence of precisions medicines in clinical trials 

1...111213...19Page 12 of 19

Newsstand

  • Supplemento to n.9 - October 2024 NCF International n.3 - 2024
  • NCF International n.2 - 2024
  • Supplemento to n.1 - January 2024 NCF International n.1 - 2024
Newsstand
© © 2025 Tecniche Nuove Spa - All rights reserved. Registered office: Via Eritrea 21 - 20157 Milan. Share capital: 5,000,000 Euro fully paid up. Tax code, VAT number and registration with the Milan Register of Companies: 00753480151